Table 3.
Univariable | Multivariable | SIB vs SeqB, Propensity score adjusted |
||||||||
---|---|---|---|---|---|---|---|---|---|---|
Endpoint | Parameter | HR | 95%CI | p | HR | 95%CI | p | HR | 95%CI | p |
CSF | SIB | 0.90 | 0.53,1.54 | 0.703 | 1.18 | 0.67,2.09 | 0.560 | 1.15 | 0.65,2.04 | 0.621 |
SIB on the first 24 months | 0.72 | 0.38,1.34 | 0.297 | 0.95 | 0.49,1.84 | 0.877 | 0.95 | 0.48,1.85 | 0.871 | |
Sex (M vs F) | 1.64 | 0.93,2.90 | 0.087 | 1.60 | 0.90,2.84 | 0.109 | ||||
Age | 1.02 | 1.00,1.04 | 0.119 | 1.02 | 1.00,1.04 | 0.124 | ||||
Stage III vs I-II | 1.78 | 1.03,3.05 | 0.037 | 1.83 | 1.04,3.22 | 0.037 | ||||
G3 vs G2-G1 | 0.82 | 0.40,1.71 | 0.603 | 0.85 | 0.41,1.77 | 0.668 | ||||
OS | SIB | 1.15 | 0.61,2.17 | 0.674 | 1.71 | 0.86,3.40 | 0.127 | 1.51 | 0.77,2.98 | 0.235 |
Sex (M vs F) | 2.64 | 1.38,5.07 | 0.003 | 2.77 | 1.43,5.37 | 0.003 | ||||
Age | 1.03 | 1.00,1.06 | 0.043 | 1.03 | 1.00,1.06 | 0.031 | ||||
Stage III vs I-II | 2.27 | 1.17,4.38 | 0.015 | 2.64 | 1.30,5.34 | 0.007 | ||||
G3 vs G2-G1 | 1.42 | 0.66,3.06 | 0.376 | 1.48 | 0.68,3.23 | 0.326 | ||||
CIC | SIB | 0.71 | 0.34,1.47 | 0.352 | 0.87 | 0.41,1.85 | 0.713 | 0.85 | 0.39,1.83 | 0.675 |
Sex (M vs F) | 0.93 | 0.39,2.18 | 0.863 | 0.83 | 0.34,2.05 | 0.690 | ||||
Age | 1.00 | 0.98,1.03 | 0.765 | 1.00 | 0.98,1.02 | 0.878 | ||||
Stage III vs I-II | 2.09 | 0.99,4.38 | 0.052 | 2.13 | 0.97,4.70 | 0.061 | ||||
G3 vs G2-G1 | 0.44 | 0.13,1.48 | 0.184 | 0.43 | 0.13,1.45 | 0.173 |
Legend HR hazard ratio CI confidence interval, M vs F male vs female, UFS colostomy-free survival, OS Overall Survival, CIC Cumulative Incidence of colostomy